CARRA is the home for pediatric rheumatologists, pediatric rheumatology research, and patients and families, as well as THE resource of pediatric rheumatology data through the CARRA Registry & Biorepository.
Our partners drive transformational change in pediatric rheumatology through:
Innovation & New Science
Ongoing research in immune-mediated diseases and treatment pathways to change the course of disease in children.
Improving Standards of Care
Enabling earlier, more effective interventions, helping children achieve remission or low-disease activity sooner, and improving quality of life.
Supporting a Critical Ecosystem
Investing in the next generation of pediatric rheumatologists, collaborating and engaging with patient families, and accelerating the drug development process.
Accelerating Treatment Options
Thought leadership on de-risking clinical trials through application of innovative alternative approaches, FDA and EMA harmonization, and partnership with the FDA.
Why Partner with CARRA?
CARRA is leading a collaborative initiative to convene the FDA and other stakeholders to accelerate treatment development by identifying and addressing major barriers to accelerating pediatric drug development.
Our community encompasses 90% of pediatric rheumatologists, and our Annual Scientific Meeting is the largest gathering in North America for the field. CARRA has 50+ workgroups focused on disease-specific research, as well as broader issues like mental health, pain, transition care, and vaccinations.
CARRA engages with a robust network of patient and families for feedback and focus groups to support patient-centered research and drug development.
More than 16,000 patients are enrolled in the CARRA Registry, THE resource for pediatric rheumatology data. Leveraging Registry data and biosamples helps propel multi-center research more economically and efficiently.
CARRA offers multiple early-career grants and hosts PREIM, a national forum for early-career investigators to showcase their research and build a network that fosters long-term collaboration, mentorship, and career development.
CARRA believes that partnerships transform pediatric rheumatology. We would love to talk about opportunities to work together to advance pediatric rheumatology and life-changing research. Please contact CARRA’s Corporate Partnerships Director, Amy Beith at [email protected] or at (404) 323-4487 to discuss collaborative partnerships.
Our partners are changing what’s possible for children living with rheumatic disease. Come join us!
Corporate Partners
